Market Cap

Welgene Biotech Co.,Ltd. Market Capitalization:

TW$525.5 Million

TWD as of Jan. 1, 2024

US$17.1 Million

business Welgene Biotech Co.,Ltd. Company Profile

Welgene Biotech Co.,Ltd. Main Stock Listing

TWSE: 6661

Market Capitalization History of Welgene Biotech Co.,Ltd.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Diagnostics & Research
Company Market Cap (USD)
Thermo Fisher Scientific $207.62 B
Danaher $171.89 B
Siemens Healthineers AG $66.05 B
DexCom, Inc. $46.50 B
IDEXX Laboratories, Inc. $44.72 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Welgene Biotech Co.,Ltd. market cap

Date Market Cap YoY Change
Jan. 1, 2024 TW$525.5 M 1.12%
Jan. 1, 2023 TW$519.7 M 1.83%
Jan. 1, 2022 TW$510.4 M -22.06%
Jan. 1, 2021 TW$654.8 M 8.12%
Jan. 1, 2020 TW$605.7 M 26.78%
Jan. 1, 2019 TW$477.7 M -4.45%
Jan. 1, 2018 TW$500.0 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Welgene Biotech Co.,Ltd. Categories

Taiwan languages Healthcare languages Diagnostics & Research
Taiwan Healthcare Taiwan Diagnostics & Research

Stocks & Indices

Welgene Biotech Co.,Ltd. has the following listings and related stock indices.


Stock: TWSE: 6661

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.